These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36409180)

  • 21. Glucocorticoids dexamethasone and prednisolone suppress fibroblast growth factor 23 (FGF23).
    Feger M; Ewendt F; Strotmann J; Schäffler H; Kempe-Teufel D; Glosse P; Stangl GI; Föller M
    J Mol Med (Berl); 2021 May; 99(5):699-711. PubMed ID: 33517471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FGF23 and mineral metabolism in the early post-renal transplantation period.
    Wesseling-Perry K; Pereira RC; Tsai E; Ettenger R; Jüppner H; Salusky IB
    Pediatr Nephrol; 2013 Nov; 28(11):2207-15. PubMed ID: 23852336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
    Stubbs J; Liu S; Quarles LD
    Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport.
    Kolek OI; Hines ER; Jones MD; LeSueur LK; Lipko MA; Kiela PR; Collins JF; Haussler MR; Ghishan FK
    Am J Physiol Gastrointest Liver Physiol; 2005 Dec; 289(6):G1036-42. PubMed ID: 16020653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic potential of klotho-FGF23 fusion polypeptides: WO2009095372.
    Razzaque MS
    Expert Opin Ther Pat; 2010 Jul; 20(7):981-5. PubMed ID: 20459364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triennial Growth Symposium: a novel pathway for vitamin D-mediated phosphate homeostasis: implications for skeleton growth and mineralization.
    Crenshaw TD; Rortvedt LA; Hassen Z
    J Anim Sci; 2011 Jul; 89(7):1957-64. PubMed ID: 21097685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New insights into the role of fibroblast growth factor 23 in chronic kidney disease.
    Nakai K; Komaba H; Fukagawa M
    J Nephrol; 2010; 23(6):619-25. PubMed ID: 20658451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteo-renal regulation of systemic phosphate metabolism.
    Razzaque MS
    IUBMB Life; 2011 Apr; 63(4):240-7. PubMed ID: 21438115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FGF23 associated bone diseases.
    Liao E
    Front Med; 2013 Mar; 7(1):65-80. PubMed ID: 23471660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FGF23 functions and disease.
    Cipriani C; Minisola S; Colangelo L; DE Martino V; Ferrone F; Biamonte F; Danese V; Sonato C; Santori R; Occhiuto M; Pepe J
    Minerva Endocrinol (Torino); 2022 Dec; 47(4):437-448. PubMed ID: 33792238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system.
    Prié D; Friedlander G
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1717-22. PubMed ID: 20798257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enigmatic Cassandra: renal FGF23 formation in polycystic kidney disease.
    Lang F; Föller M
    Kidney Int; 2014 Jun; 85(6):1260-2. PubMed ID: 24875546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythropoietin stimulates fibroblast growth factor 23 (FGF23) in mice and men.
    Daryadel A; Bettoni C; Haider T; Imenez Silva PH; Schnitzbauer U; Pastor-Arroyo EM; Wenger RH; Gassmann M; Wagner CA
    Pflugers Arch; 2018 Oct; 470(10):1569-1582. PubMed ID: 29961920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary phosphate restriction suppresses phosphaturia but does not prevent FGF23 elevation in a mouse model of chronic kidney disease.
    Zhang S; Gillihan R; He N; Fields T; Liu S; Green T; Stubbs JR
    Kidney Int; 2013 Oct; 84(4):713-21. PubMed ID: 23698235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations.
    Yu X; Sabbagh Y; Davis SI; Demay MB; White KE
    Bone; 2005 Jun; 36(6):971-7. PubMed ID: 15869926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fgf23 and parathyroid hormone signaling interact in kidney and bone.
    Andrukhova O; Streicher C; Zeitz U; Erben RG
    Mol Cell Endocrinol; 2016 Nov; 436():224-39. PubMed ID: 27498418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physiology of the Calcium-Parathyroid Hormone-Vitamin D Axis.
    Goltzman D; Mannstadt M; Marcocci C
    Front Horm Res; 2018; 50():1-13. PubMed ID: 29597231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The parathyroid is a target organ for FGF23 in rats.
    Ben-Dov IZ; Galitzer H; Lavi-Moshayoff V; Goetz R; Kuro-o M; Mohammadi M; Sirkis R; Naveh-Many T; Silver J
    J Clin Invest; 2007 Dec; 117(12):4003-8. PubMed ID: 17992255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid genomic changes by mineralotropic hormones and kinase SIK inhibition drive coordinated renal Cyp27b1 and Cyp24a1 expression via CREB modules.
    Meyer MB; Benkusky NA; Lee SM; Yoon SH; Mannstadt M; Wein MN; Pike JW
    J Biol Chem; 2022 Nov; 298(11):102559. PubMed ID: 36183832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone-kidney axis in systemic phosphate turnover.
    Razzaque MS
    Arch Biochem Biophys; 2014 Nov; 561():154-8. PubMed ID: 24997362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.